Torigen Pharmaceuticals, Inc.

Torigen Pharmaceuticals, Inc.

Private
Farmington, ConnecticutHealthcare & Life Scienceshttps://www.torigen.com/

Last Round

Series A

Extension

Nov 16, 2022

Total Funding Raised

$21.5M

Momentum Score

50 /100

Company Overview

Torigen Pharmaceuticals, Inc. is a biotechnology company that provides personalized cancer immunotherapies for companion animals.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting, Hardware Sales

AI Layer

Non-AI

Keywords

autologous cancer vaccineveterinary immunotherapyanimal cancer treatmentpet cancer treatmentveterinary oncologycompanion animal healthpersonalized immunotherapyvet techanimal healthveterinary pathologyanimal biotechhistopathology servicesin-clinic vaccine kitveterinary biologics

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Torigen Pharmaceuticals, Inc. Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Torigen Pharmaceuticals, Inc. Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
Series A ExtensionNov 16, 2022
Series AMar 4, 2021
Series AFeb 4, 2019
Convertible DebtOct 20, 2017
Convertible DebtMar 23, 2017

Key People

Founding team and executive leadership

Ashley Kalinauskas

Chief Executive Officer

Executive Team

Torigen Pharmaceuticals, Inc. Investors

Notable investors and investment history

InvestorRounds
Connecticut InnovationsSeries A, Series A Extension, Convertible Debt
Emerald Development ManagersSeries A Extension, Series A
Advantage CapitalSeries A Extension
GaingelsSeries A Extension, Series A
Werth Family Investment AssociatesSeries A Extension
SoGal VenturesSeries A Extension, Series A
Sofia FundSeries A

Torigen Pharmaceuticals, Inc. Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Torigen Pharmaceuticals, Inc. Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Torigen Pharmaceuticals, Inc.'s valuation, stock price, and market status.

Firmographic Details

HeadquartersFarmington, Connecticut
Employee Range22
Year Founded2013
Last FundingNov 16, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.